Literature DB >> 3827365

Atrial caval shunting in blunt hepatic vascular injury.

P F Rovito.   

Abstract

Of 51 patients with major blunt hepatic trauma treated at a Level I trauma center, 29 patients (56.8%) survived. Nine of the 51 patients required insertion of the atrial caval shunt, as indicated by uncontrollable hemorrhage due to disruption of the perihepatic veins. Eight of these nine patients sustained injury to the hepatic veins or the retrohepatic vena cava. Of the eight patients with hepatic vascular injury, four (50.0%) were long-term survivors. In hepatic trauma patients with suspected hepatic vascular injury, aggressive use of the shunt can control hemorrhage before the onset of coagulopathy or hypothermia.

Entities:  

Mesh:

Year:  1987        PMID: 3827365      PMCID: PMC1492701          DOI: 10.1097/00000658-198703000-00017

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  12 in total

1.  Isolation of the retrohepatic vena cava by balloon catheter: an experimental assessment.

Authors:  W S Aaron; E T Mays
Journal:  Rev Surg       Date:  1975 May-Jun

2.  The rationale of surgery under hypothermia in certain patients with severe hepatocellular disease.

Authors:  W F BERNHARD; G F CAHILL; G W CURTIS
Journal:  Ann Surg       Date:  1957-03       Impact factor: 12.969

3.  An improved technic for vascular isolation of the liver: experimental study and case reports.

Authors:  J P Heaney; W K Stanton; D S Halbert; J Seidel; T Vice
Journal:  Ann Surg       Date:  1966-02       Impact factor: 12.969

4.  Vascular isolation in treatment of juxtahepatic venous injuries.

Authors:  A E Yellin; C B Chaffee; A J Donovan
Journal:  Arch Surg       Date:  1971-06

5.  Surgical management of injuries to the vena cava: changing patterns of injury and newer techniques of repair.

Authors:  D L Bricker; J R Morton; J E Okies; A C Beall
Journal:  J Trauma       Date:  1971-09

6.  Management of blunt trauma to the liver and hepatic veins.

Authors:  T Schrock; F W Blaisdell; C Mathewson
Journal:  Arch Surg       Date:  1968-05

7.  Hypotension following revascularization of the anoxic liver: factors influencing its occurrence and prevention.

Authors:  G D Buckberg; H Ono; W L Joseph; J A Tocornal; E W Fonkalsrud; W P Longmire
Journal:  Surgery       Date:  1968-03       Impact factor: 3.982

8.  Atrial-caval shunting (ACS) after trauma.

Authors:  K A Kudsk; G F Sheldon; R C Lim
Journal:  J Trauma       Date:  1982-02

9.  Major hepatic vein ligation necessitated by blunt abdominal trauma.

Authors:  D J Depinto; S J Mucha; P C Powers
Journal:  Ann Surg       Date:  1976-03       Impact factor: 12.969

10.  Injuries of hepatic veins and retrohepatic vena cava.

Authors:  B Misra; R Wagner; H Boneval
Journal:  Am Surg       Date:  1983-01       Impact factor: 0.688

View more
  7 in total

1.  Continuing evolution in the approach to severe liver trauma.

Authors:  D V Feliciano
Journal:  Ann Surg       Date:  1992-11       Impact factor: 12.969

2.  Hepatic vein and retrohepatic vena caval injury.

Authors:  K F Ciresi; R C Lim
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

Review 3.  Management of traumatic retroperitoneal hematoma.

Authors:  D V Feliciano
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

4.  Significant trends in the treatment of hepatic trauma. Experience with 411 injuries.

Authors:  H L Pachter; F C Spencer; S R Hofstetter; H G Liang; G F Coppa
Journal:  Ann Surg       Date:  1992-05       Impact factor: 12.969

5.  The atriocaval shunt. Facts and fiction.

Authors:  J M Burch; D V Feliciano; K L Mattox
Journal:  Ann Surg       Date:  1988-05       Impact factor: 12.969

6.  Management of liver trauma in adults.

Authors:  Nasim Ahmed; Jerome J Vernick
Journal:  J Emerg Trauma Shock       Date:  2011-01

Review 7.  Management of liver trauma.

Authors:  S A Badger; R Barclay; P Campbell; D J Mole; T Diamond
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.